Kiora Pharmaceuticals to Present Additional Data from Its ABACUS-1 Trial in Retinitis Pigmentosa at the ARVO 2024 Annual Meeting

Kiora Pharmaceuticals, Inc. , announced that additional data from the ABACUS-1 trial has been accepted for presentation at the Association for Research in Vision and Ophthalmology meeting in...

Related Keywords

United States ,Adelaide ,South Australia ,Australia ,Kiora ,New South Wales ,American ,Robert James Casson ,Linkedin ,Twitter ,American Academy Of Ophthalmology ,Science At Adelaide University ,Kiora Pharmaceuticals ,California Newsfile Corp ,Kiora Pharmaceuticals Inc ,Nasdaq ,Association For Research ,Professor Robert James Casson ,Visual Science ,American Academy ,Open Innovation ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,